Euclidean Capital LLC Oric Pharmaceuticals, Inc. Transaction History
Euclidean Capital LLC
- $735 Million
- Q4 2024
A detailed history of Euclidean Capital LLC transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Euclidean Capital LLC holds 989,410 shares of ORIC stock, worth $7.29 Million. This represents 1.09% of its overall portfolio holdings.
Number of Shares
989,410
Previous 989,410
-0.0%
Holding current value
$7.29 Million
Previous $10.1 Million
21.27%
% of portfolio
1.09%
Previous 1.12%
Shares
5 transactions
Others Institutions Holding ORIC
# of Institutions
131Shares Held
67.2MCall Options Held
404KPut Options Held
6.4K-
Nextech Invest Ag5.29MShares$39 Million7.95% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$35.6 Million0.0% of portfolio
-
Viking Global Investors LP4.43MShares$32.7 Million0.12% of portfolio
-
Vr Adviser, LLC New York, NY4.39MShares$32.4 Million5.85% of portfolio
-
Alkeon Capital Management LLC New York, NY3.9MShares$28.8 Million0.07% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $292M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...